Categories
Mylan Pharmaceuticals Inc., a Viatris company, is voluntarily recalling one batch of Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens which are packaged in cartons of five pens to the consumer level. This product is not the branded Semglee® pen but the un
Categories
FDA Roundup: July 5, 2022
FDA Roundup: July 5, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-july-5-2022
Categories
Information Regarding Medically Necessary Specialty Infant Formulas: Notice to Health Care Providers
The FDA is providing information to health care professionals to help their patients obtain access to medically necessary specialty formulas, the amino acid-based and the metabolic infant formula products.
Categories
FDA Roundup: July 1, 2022
FDA Roundup: July 1, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-july-1-2022
Categories
FDA Infant Formula Update: June 30, 2022
FDA Infant Formula Update: June 30, 2022
http://www.fda.gov/news-events/press-announcements/fda-infant-formula-update-june-30-2022
Categories
Coronavirus (COVID-19) Update: FDA Recommends Inclusion of Omicron BA.4/5 Component for COVID-19 Vaccine Booster Doses
Coronavirus (COVID-19) Update: FDA Recommends Inclusion of Omicron BA.4/5 Component for COVID-19 Vaccine Booster Doses
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-recommends-inclusion-omicron-ba45-component-covid-19-vaccine-booster
Categories
Update: Mammography Problems at Capitol Radiology, LLC, doing business as Laurel Radiology Services in Laurel, Maryland: FDA Safety Communication
The FDA is alerting patients who had mammograms at Capitol Radiology, LLC on or after June 26, 2018, about possible problems with the quality of mammograms.
Categories
Use Duodenoscopes with Innovative Designs to Enhance Safety: FDA Safety Communication
Use Duodenoscopes with Innovative Designs to Enhance Safety: FDA Safety Communication
Categories
Bryant Ranch Prepack Inc. Issues Voluntary Nationwide Recall of Morphine Sulfate 30 mg Extended Release and Morphine Sulfate 60 mg Extended-Release Due to Label-Mix Up
Burbank, California, Bryant Ranch Prepack Inc. is voluntarily recalling one lot of Morphine Sulfate 30 mg Extended-Release tablets (Comprised of 10 bottles), and one lot of Morphine Sulfate 60 mg Extended-Release tablets (Comprised of 10 bottles) to the consumer level listed in the table below. The
Categories
FDA Roundup: June 28, 2022
FDA Roundup: June 28, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-june-28-2022